We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,992 hedge funds and large institutions have $254B invested in Johnson & Johnson in 2020 Q2 according to their latest regulatory filings, with 158 funds opening new positions, 1,373 increasing their positions, 1,187 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 158 | Existing positions closed: 67

16% more repeat investments, than reductions

Existing positions increased: 1,373 | Existing positions reduced: 1,187

6% more capital invested

Capital invested by funds: $240B → $254B (+$14.2B)

2% more funds holding

Funds holding: 2,9332,992 (+59)

0.62% less ownership

Funds ownership: 69.74%69.12% (-0.62%)

7% less call options, than puts

Call options by funds: $1.89B | Put options by funds: $2.02B

19% less funds holding in top 10

Funds holding in top 10: 759618 (-141)

Holders
2,992
Holders Change
+59
Holders Change %
+2.01%
% of All Funds
61.34%
Holding in Top 10
618
Holding in Top 10 Change
-141
Holding in Top 10 Change %
-18.58%
% of All Funds
12.67%
New
158
Increased
1,373
Reduced
1,187
Closed
67
Calls
$1.89B
Puts
$2.02B
Net Calls
-$138M
Net Calls Change
-$457M
Name Holding Trade Value Shares
Change
Change in
Stake
OCM
1401
Olstein Capital Management
New York
$3.66M +$3.79M +26,000 New
CA
1402
Cornerstone Advisory
Maryland
$3.65M +$1.34M +9,193 +55%
VCM
1403
Vision Capital Management
Oregon
$3.65M -$141K -968 -4%
DFA
1404
Delta Financial Advisors
Louisiana
$3.65M -$43K -295 -1%
TAM
1405
Tealwood Asset Management
Minnesota
$3.63M -$17.8K -122 -0.5%
SCM
1406
Southport Capital Management
Tennessee
$3.62M +$27.7K +190 +0.7%
JAM
1407
Jupiter Asset Management
United Kingdom
$3.61M -$4.86M -33,337 -56%
MMPW
1408
Mitchell McLeod Pugh & Williams
Alabama
$3.61M +$675K +4,633 +22%
AL
1409
Arnhold LLC
New York
$3.6M
CIP
1410
Capital Insight Partners
Arizona
$3.59M +$1.02M +6,986 +38%
CCM
1411
Compton Capital Management
Rhode Island
$3.59M -$47.4K -325 -1%
BP
1412
Ballentine Partners
Massachusetts
$3.59M +$66.6K +457 +2%
PIM
1413
Platinum Investment Management
Australia
$3.58M
Capital Fund Management (CFM)
1414
Capital Fund Management (CFM)
France
$3.58M -$19.9M -136,630 -84%
BJL
1415
Brighton Jones LLC
Washington
$3.58M -$195K -1,338 -5%
MWM
1416
Minot Wealth Management
Massachusetts
$3.58M +$1.15M +7,877 +45%
BCM
1417
Brookstone Capital Management
Illinois
$3.58M -$122K -834 -3%
MCM
1418
Manchester Capital Management
Vermont
$3.57M +$76.5K +525 +2%
SC
1419
Stralem & Co
New York
$3.57M -$51K -350 -1%
CFSG
1420
Community Financial Services Group
Vermont
$3.57M -$163K -1,116 -4%
RA
1421
Rational Advisors
New York
$3.56M +$2.47M +16,956 +202%
PMG
1422
ProVise Management Group
Florida
$3.56M +$70.8K +486 +2%
TCM
1423
Traynor Capital Management
Pennsylvania
$3.56M +$752K +5,157 +26%
CST
1424
Charles Schwab Trust
Nevada
$3.55M -$456K -3,127 -11%
MWM
1425
Mattern Wealth Management
Kansas
$3.54M -$183K -1,259 -5%

JNJ Hedge Fund Activity: Q2 2020 in Review

2,992 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2020, worth a combined $254B — up 5.9% from $240B a quarter earlier.

Buyers outnumbered sellers: 158 funds opened new JNJ positions and 67 closed out — a net gain of 91 holders — while 1,373 added to existing stakes and 1,187 trimmed.

The largest buyer was Nordea Investment Management, adding an estimated $1.17B. The largest seller was Osaic Holdings, cutting an estimated $1.25B.

  • 2,992 institutional investors held Johnson & Johnson (JNJ) as of Q2 2020, up from 2,933 in Q1 2020.
  • Funds reported $254B of Johnson & Johnson stock for Q2 2020, up 5.9% quarter-over-quarter.
  • 158 funds opened new Johnson & Johnson positions in Q2 2020 and 67 closed out, a net change of +91 holders.
  • The largest Johnson & Johnson buyer in Q2 2020 was Nordea Investment Management, an estimated $1.17B added.
  • The largest Johnson & Johnson seller in Q2 2020 was Osaic Holdings, an estimated $1.25B sold.

Based on aggregated 13F filings for Q2 2020.